ProFound AI® Risk is the first image-based, one or two year risk assessment tool
As the field of mammography moves from age-based screening recommendations to more personalized risk-adaptive screening guidelines, iCAD is on the leading-edge of this exciting new realm that will enable clinicians to easily adapt to evolving screening practices and personalize patient care.
Good just isn’t good enough.
ProFound Risk is 2.4x more accurate compared to traditional models.
Traditional Mammograms
With traditional mammograms, there’s a 25-40% reduction in mortality risk.
However, the reduction is only when cancer is detected early, and 40% of cancers are still detected at a later stage. And 10-15% of all cancers are detected in the interval between scheduled mammograms, which are either entirely missed or masked during the previous mammogram.
When radiologists apply traditional models and clinical guidelines to a patient who has a 20%+ lifetime risk of breast cancer score, they usually recommend an MRI for supplemental screening.
However, tests often result in a high number of false positives due to low-to-moderate discrimination performance, such as specificity and sensitivity. Patients deserve a better solution.
ProFound AI Risk uses a new model for predicting breast cancer risk during an annual mammogram screening. By evaluating several data points in the patient and scan image, it calculates a more accurate short-term Risk Score of developing breast cancer.
The result? For higher risk scores, it identifies women who may benefit from supplemental screening or a personalized screening interval, despite a negative or benign finding.